Casdin Capital, LLC Q4 2023 Filing
Filed February 14, 2024
Portfolio Value
$1.0B
Holdings
36
Report Date
Q4 2023
Filing Type
13F-HR
All Holdings (36 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | RVMDREVOLUTION MEDICINES INC | 5,714,775 | $163.9T | 16088492.44% | |
| 2 | BLFSBIOLIFE SOLUTIONS INC | 8,707,165 | $141.5T | 13888879.39% | |
| 3 | SRPTSAREPTA THERAPEUTICS INC | 1,006,500 | $97.1T | 9527150.23% | |
| 4 | RLAYRELAY THERAPEUTICS INC | 7,387,943 | $81.3T | 7984503.59% | |
| 5 | ILMNILLUMINA INC | 338,000 | $47.1T | 4619742.64% | Call |
| 6 | GPCRSTRUCTURE THERAPEUTICS INC | 1,116,867 | $45.5T | 4468612.57% | Call |
| 7 | NTLAINTELLIA THERAPEUTICS INC | 1,450,000 | $44.2T | 4339727.84% | |
| 8 | VERVVERVE THERAPEUTICS INC | 3,009,094 | $41.9T | 4117518.81% | |
| 9 | ALNYALNYLAM PHARMACEUTICALS INC | 195,000 | $37.3T | 3663838.33% | |
| 10 | SLGCUSDSOMALOGIC INC | 12,604,275 | $31.9T | 3130224.33% | |
| 11 | EXASEXACT SCIENCES CORP | 420,000 | $31.1T | 3050005.94% | |
| 12 | 2L9BLUEPRINT MEDICINES CORP | 326,378 | $30.1T | 2955134.44% | |
| 13 | PLRXPLIANT THERAPEUTICS INC | 1,577,108 | $28.6T | 2803605.83% | |
| 14 | DNLIDENALI THERAPEUTICS INC | 1,300,000 | $27.9T | 2738483.56% | |
| 15 | FDMT4D MOLECULAR THERAPEUTICS IN | 1,033,811 | $20.9T | 2055974.20% | |
| 16 | TNYATENAYA THERAPEUTICS INC | 6,381,377 | $20.7T | 2029534.65% | |
| 17 | BEAMBEAM THERAPEUTICS INC | 528,000 | $14.4T | 1410779.40% | |
| 18 | ABCLABCELLERA BIOLOGICS INC | 2,360,129 | $13.5T | 1322844.91% | |
| 19 | TNGXTANGO THERAPEUTICS INC | 1,188,349 | $11.8T | 1154825.23% | |
| 20 | IPSCCENTURY THERAPEUTICS INC | 3,206,380 | $10.6T | 1044937.12% | |
| 21 | RNAAVIDITY BIOSCIENCES INC | 1,175,750 | $10.6T | 1044481.27% | |
| 22 | NGNENEUROGENE INC | 524,616 | $10.2T | 998004.20% | |
| 23 | PACBPACIFIC BIOSCIENCES CALIF IN | 1,035,859 | $10.2T | 997485.81% | |
| 24 | WGSGENEDX HOLDINGS CORP | 3,095,511 | $8.5T | 835607.06% | |
| 25 | FATEFATE THERAPEUTICS INC | 2,050,000 | $7.7T | 752597.08% | |
| 26 | CDXSCODEXIS INC | 2,000,000 | $6.1T | 598779.47% | |
| 27 | TSVT*2SEVENTY BIO INC | 1,182,623 | $5.0T | 495691.24% | |
| 28 | ABSIABSCI CORPORATION | 973,260 | $4.1T | 401250.17% | |
| 29 | PRMEPRIME MEDICINE INC | 367,175 | $3.3T | 319333.12% | |
| 30 | SNDXSYNDAX PHARMACEUTICALS INC | 150,000 | $3.2T | 318187.48% | |
| 31 | GLUEMONTE ROSA THERAPEUTICS INC | 510,882 | $2.9T | 283338.81% | |
| 32 | FLBSTANDARD BIOTOOLS INC | 1,200,000 | $2.7T | 260321.83% | |
| 33 | EXAIEUREXSCIENTIA PLC | 213,900 | $1.4T | 134587.86% | |
| 34 | LIANYLIANBIO | 206,415 | $922.7B | 90570.30% | |
| 35 | —SINGULAR GENOMICS SYSTEMS IN | 1,323,885 | $609.1B | 59791.47% | |
| 36 | KRON1USDKRONOS BIO INC | 123,839 | $154.8B | 15195.16% |